Strength
20 mg/g
Manufacturer
Pfizer Inc.NDC
55724021111
Classification
Brand
Dosage Form
OINTMENT
Route
TOPICAL
Last Updated
4/22/2026
Active Ingredients
CRISABOROLEApproval Type
New Drug (NDA)
FDA Application
NDA207695On Market Since
1/30/2017
Pharmacological Classes
Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors
Related Drugs
Same classification
DALIRESP 250 MCG TABLET
Brand
00310008828•AstraZeneca Pharmaceuticals LP
$14.9826
per EA
DALIRESP 250 MCG TABLET
Brand
00310008839•AstraZeneca Pharmaceuticals LP
$14.9826
per EA
DALIRESP 500 MCG TABLET
Brand
00310009530•AstraZeneca Pharmaceuticals LP
$15.0027
per EA
DALIRESP 500 MCG TABLET
Brand
00310009590•AstraZeneca Pharmaceuticals LP
$15.0027
per EA
ZORYVE 0.15% CREAM
Brand
80610011560•Arcutis Biotherapeutics, Inc.
$15.3893
per GM
ZORYVE 0.3% CREAM
Brand
80610013060•Arcutis Biotherapeutics, Inc.
$15.3897
per GM
ZORYVE 0.3% FOAM
Brand
80610043060•Arcutis Biotherapeutics, Inc.
$15.3897
per GM
OTEZLA 20 MG TABLET
Brand
55513049760•Amgen Inc.
$89.9522
per EA
OTEZLA 30 MG TABLET
Brand
55513013760•Amgen Inc.
$90.6993
per EA